Evidence map›Paper›PMID 40535485›Full record

ArticleWorld journal of transplantation2025

Changes in the liver transplant evaluation process during the early COVID-19 era and the role of telehealth.

Ashley H Jowell, Allison J Kwong, Reshma Reguram, Tami J Daugherty, Paul Yien Kwo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ashley H JowellDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, United States.
Allison J KwongDepartment of Medicine, Stanford University, Redwood City, CA 94063, United States.
Reshma ReguramDepartment of Medicine, Trinity Health, Pontiac, MI 48341, United States.
Tami J DaughertyDepartment of Medicine, Stanford University, Redwood City, CA 94063, United States.
Paul Yien KwoDepartment of Medicine, Stanford University, Redwood City, CA 94063, United States. pkwo@stanford.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) disrupted healthcare and led to increased telehealth use. We explored the impact of COVID-19 on liver transplant evaluation (LTE).

aimTo understand the impact of telehealth on LTE during COVID-19 and to identify disparities in outcomes disaggregated by sociodemographic factors.

methodsThis was a retrospective study of patients who initiated LTE at our center from 3/16/20-3/16/21 ("COVID-19 era") and the year prior (3/16/19-3/15/20, "pre-COVID-19 era"). We compared LTE duration times between eras and explored the effects of telehealth and inpatient evaluations on LTE duration, listing, and pre-transplant mortality.

resultsOne hundred and seventy-eight patients were included in the pre-COVID-19 era cohort and one hundred and ninety-nine in the COVID-19 era cohort. Twenty-nine percent (58/199) of COVID-19 era initial LTE were telehealth, compared to 0% (0/178) pre-COVID-19. There were more inpatient evaluations during COVID-19 era (40%

conclusionCOVID-19 demonstrates a shift to telehealth and inpatient LTE. Telehealth does not impact LTE or listing duration, likelihood of listing, or mortality, suggesting telehealth may facilitate LTE without negative outcomes.

Indexed as

COVID-19Health accessHealth equityLiver transplant evaluationTelehealth

Identifiers

PMID40535485
PMCPMC11886291

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.